BioNTech says the COVID vaccine it has developed with Pfizer is likely to be as effective against the Indian variant of coronavirus as it is against the South African strain.
BioNTech says the COVID vaccine it has developed with Pfizer is likely to be as effective against the Indian variant of coronavirus as it is against the South African strain.